Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

Lilly files new class migraine drug with FDA

pharmaphorumDecember 05, 2018

Tag: Lilly , class migraine drug , FDA , 5-HT1F agonist

PharmaSources Customer Service